Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd CVALF


Primary Symbol: V.COV

Healthcare Biotechnology
Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Business Wire February 28, 2020

Covalon Announces Fiscal 2019 Year-End Results and Plans for Fiscal 2020

Business Wire January 28, 2020

Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results

Business Wire January 27, 2020

Covalon Announces Closing of Non-Brokered Private Placement

Business Wire September 18, 2019

Covalon Announces Re-Pricing of Private Placement

Business Wire September 6, 2019

Covalon Announces Third Quarter Fiscal 2019 Results

Business Wire August 27, 2019

Covalon Announces Private Placement of Up To $6.3 Million

Business Wire August 1, 2019

Covalon CEO Provides Corporate Update

Business Wire July 25, 2019

Covalon Announces Second Quarter Fiscal 2019 Results

Business Wire May 28, 2019

Covalon Announces Conference Call to Discuss Second Quarter Financial Results

Business Wire May 27, 2019

Covalon’s Award-Winning MediClear PreOp Product Recognized as Innovative Solution to Help Hospitals Reduce Surgical Site Infections

Business Wire April 8, 2019

Mr. Ron Smith Joins Covalon’s Board of Directors and is Appointed Chair of the Audit Committee

Business Wire March 18, 2019

Covalon Announces Voting Results from 2019 Annual and Special Meeting of Shareholders

Business Wire March 8, 2019

Covalon Announces First Quarter Fiscal 2019 Results and Updates Plans for Fiscal 2019

Business Wire February 26, 2019

Covalon Announces Conference Call to Discuss First Quarter Financial Results

Business Wire February 21, 2019

Mr. John Suk Joins Covalon’s Board of Directors

Business Wire January 30, 2019

Dr. Myrna Francis Joins Covalon’s Board of Directors

Business Wire January 28, 2019

Covalon Announces Change of Auditors and Amends and Restates Its Rolling Stock Option Plan

Business Wire January 24, 2019

Covalon Announces Issuance of Stock Options

Business Wire December 27, 2018

Covalon Announces Fiscal 2018 Year-End Results and Plans for Fiscal 2019

Business Wire December 17, 2018